As we gear up to enter the second quarter of 2024, a retrospective analysis reveals a significant decrease in the number of novel drugs approved during the first quarter of this year.The data indicates that only six novel drugs secured FDA nod in the first quarter of this year, compared to thirteen approvals during the same period last year. Against this backdrop, let's take a look at the list of ...
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.